Olopade OI - Search Results

1

Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients.

Benson AB 3rd, Olopade OI, Ratain MJ, Rademaker A, Mobarhan S, Stucky-Marshall L, French S, Dolan ME. Benson AB 3rd, et al. Among authors: olopade oi. Clin Cancer Res. 2000 Oct;6(10):3870-7. Clin Cancer Res. 2000. PMID: 11051232 Clinical Trial.

2

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

Gupta E, Olopade OI, Ratain MJ, Mick R, Baker TM, Berezin FK, Benson AB 3rd, Dolan ME. Gupta E, et al. Among authors: olopade oi. Clin Cancer Res. 1995 Oct;1(10):1133-8. Clin Cancer Res. 1995. PMID: 9815904

3

Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.

Wu MH, Lohrbach KE, Olopade OI, Kokkinakis DM, Friedman HS, Dolan ME. Wu MH, et al. Among authors: olopade oi. Clin Cancer Res. 1999 Jan;5(1):209-13. Clin Cancer Res. 1999. PMID: 9918221

4

Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.

Poelman SM, Adeyanju MO, Robertson MA, Recant WM, Karrison T, Fleming GF, Olopade OI, Conzen SD. Poelman SM, et al. Among authors: olopade oi. Clin Cancer Res. 2000 Oct;6(10):4043-8. Clin Cancer Res. 2000. PMID: 11051254

5

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ. O'Donnell PH, et al. Among authors: olopade oi. Clin Pharmacol Ther. 2017 Nov;102(5):859-869. doi: 10.1002/cpt.709. Epub 2017 Jun 15. Clin Pharmacol Ther. 2017. PMID: 28398598 Free PMC article.

6

Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.

Stadler WM, Steinberg G, Yang X, Hagos F, Turner C, Olopade OI. Stadler WM, et al. Among authors: olopade oi. Clin Cancer Res. 2001 Jun;7(6):1676-82. Clin Cancer Res. 2001. PMID: 11410506

7

Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.

Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO. Olopade OI, et al. Cancer Res. 1992 May 1;52(9):2523-9. Cancer Res. 1992. PMID: 1568221

8

Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.

Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI. Dreyling MH, et al. Among authors: olopade oi. Cancer Res. 1995 Mar 1;55(5):984-8. Cancer Res. 1995. PMID: 7867008

9

Parity and breastfeeding are protective against breast cancer in Nigerian women.

Huo D, Adebamowo CA, Ogundiran TO, Akang EE, Campbell O, Adenipekun A, Cummings S, Fackenthal J, Ademuyiwa F, Ahsan H, Olopade OI. Huo D, et al. Among authors: olopade oi. Br J Cancer. 2008 Mar 11;98(5):992-6. doi: 10.1038/sj.bjc.6604275. Epub 2008 Feb 26. Br J Cancer. 2008. PMID: 18301401 Free PMC article.

10

Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.

Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI. Stadler WM, et al. Among authors: olopade oi. Cancer Res. 1994 Apr 15;54(8):2060-3. Cancer Res. 1994. PMID: 7513608

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

521 results

Search Page

Filters